Stock Events

ARK Genomic Revolution 

$25.03
1003
+$0+0% Friday 16:38

Statistics

Day High
25.71
Day Low
25.03
52W High
38.55
52W Low
21.99
Volume
140
Avg. Volume
9,026
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0CQL.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Global X Genomics & Biotechnology
GNOM
Mkt Cap94.89M
Global X Genomics & Biotechnology ETF, focuses on companies in genomics, making it a direct competitor to ARKG's thematic investment in genomics and biotech.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap134.21M
iShares Genomics Immunology and Healthcare ETF, targets similar genomics and immunology sectors, directly competing with ARKG's investment focus.
Principal Healthcare Innovators
BTEC
Mkt Cap16.4M
Principal Healthcare Innovators Index ETF, invests in healthcare innovation, including genomics, competing in the same thematic space as ARKG.
Invesco Biotechnology & Genome
PBE
Mkt Cap256.41M
Invesco Dynamic Biotechnology & Genome ETF, focuses on biotech and genomic companies, making it a competitor by targeting similar investment themes.
VanEck Biotech
BBH
Mkt Cap432.58M
VanEck Vectors Biotech ETF, while broader in biotech, it includes genomic companies, positioning it as a competitor to ARKG.
SPDR Biotech
XBI
Mkt Cap6.94B
SPDR S&P Biotech ETF, offers broad exposure to biotech, including genomics, competing with ARKG on the thematic investment front.
iShares Biotechnology
IBB
Mkt Cap7.28B
iShares Nasdaq Biotechnology ETF, a broad biotech ETF that includes genomic companies, making it a competitor in the space.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap1.1B
First Trust NYSE Arca Biotechnology Index Fund, although broader, it competes by investing in some of the same genomic and biotech companies as ARKG.
ALPS Medical Breakthroughs
SBIO
Mkt Cap104.11M
ALPS Medical Breakthroughs ETF, focuses on medical breakthroughs, including genomics, positioning it as a thematic competitor.
Virtus LifeSci Biotech Clinical Trials
BBC
Mkt Cap10.16M
Virtus LifeSci Biotech Clinical Trials ETF, focuses on biotech companies in clinical trials, including genomics, making it a niche competitor.

About

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Show more...
CEO
Country
US
ISIN
US00214Q3020

Listings